Country: Australia
Language: English
Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)
G GLYCOPROTEIN OF HENDRA VIRUS (SG - PROTEIN); THIOMERSAL
ZOETIS AUSTRALIA PTY LTD
Hendra virus G-protein(100ug/mL)
MISC. VACCINES OR ANTI SERA
G GLYCOPROTEIN OF HENDRA VIRUS (SG - PROTEIN) VACCINE-VIRAL Active 100.0 ug; THIOMERSAL MERCURY Other 0.1 mg/ml
10mL; 1mL
VM - Veterinary Medicine
ZOETIS AUSTRALIA
IMMUNOTHERAPY
Poison schedule: 0; Withholding period: Zero (0) days; Host/pest details: HORSE: [HENDRA VIRUS]; Poison schedule: 0; Withholding period: ; Host/pest details: HORSE: [HENDRA VIRUS]; An aid in the prevention of clinical symptoms of the disease caused by Hendra virus in horses 4 months of age and older.This product should not be used in sick or immunocompromised horses.
Registered
2023-07-01
ZOETIS AUSTRALIA PTY LTD EQUIVAC HEV HENDRA VIRUS VACCINE FOR HORSES 68996/105049 COMPANY NAME: PRODUCT NAME: APVMA APPROVAL NO: LABEL NAME: EQUIVAC HEV HENDRA VIRUS VACCINE FOR HORSES SIGNAL HEADINGS: FOR ANIMAL TREATMENT ONLY CONSTITUENT STATEMENTS: 100 µg/mL G-PROTEIN (sG) OF HENDRA VIRUS 0.1 mg/mL THIOMERSAL CLAIMS: An aid in the prevention of clinical symptoms of the disease caused by Hendra virus in horses 4 months of age and older. NET CONTENTS: 10 mL glass vial, 1 mL glass syringe DIRECTIONS FOR USE: Read the enclosed leaflet for full instructions DIRECTIONS FOR USE CONTRAINDICATIONS: The Product should not be used in sick or immunocompromised horses. PRECAUTIONS: The effectiveness of Equivac HeV vaccine in the face of Hendra virus disease outbreak has not been studied. While all horses receiving the recommended vaccine course and booster vaccination at 6 months were antibody positive, the potential for vaccinated horses to shed virus if exposed to and infected with the Hendra virus cannot be ruled out. It is recommended that good hygiene practices are observed when horses are being handled. This product has been found to be safe for administration to pregnant mares. However, in pregnant mares it is important to avoid the use of vaccines during critical stages of pregnancy. For this reason avoid vaccinating during the first 45 days after mating and the last 14 days before the expected date of foaling. Duration of immunity has not been demonstrated for more than 6 months following the primary vaccination course. The compatibility of Equivac HeV Hendra virus vaccine with other vaccines and veterinary RLP APPROVED chemical products has not been studied. SIDE EFFECTS: Transient swelling may develop at the site of vaccination in some horses but should resolve within one week without treatment. In some horses transient post-vaccination reactions including injection site reaction, pain, increase in body temperature, lethargy, inappetence, and muscle stiffness have also been observed. Additional reported clinica Read the complete document
Issue date: 14-September-2016 Supersedes date: 14-September-2016 Revision Date: 15-September-2016 Version number: 02 SAFETY DATA SHEET 1. IDENTIFICATION EQUIVAC HEV PRODUCT IDENTIFIER OTHER MEANS OF IDENTIFICATION Equivac HeV Hendra Virus Vaccine for horses SYNONYMS RECOMMENDED USE OF THE CHEMICAL AND RESTRICTIONS ON USE Veterinary vaccine RECOMMENDED USE Not for human use RESTRICTIONS ON USE DETAILS OF MANUFACTURER OR IMPORTER MANUFACTURER COMPANY NAME (AU) Zoetis Australia Pty Ltd ABN 94 156 476 425 Level 6, 5 Rider Boulevard Rhodes NSW 2138 AUSTRALIA TEL 1800 814 883 FAX (02) 8876 0444 EMAIL australia.animalhealth@zoetis.com EMERGENCY PHONE 1800 814 883 (all hours) POLICE AND FIRE BRIGADE Dial 000 IF INEFFECTIVE Dial Poisons Information Centre (13 1126 from anywhere in Australia) 2. HAZARD(S) IDENTIFICATION CLASSIFICATION OF THE HAZARDOUS CHEMICAL Not classified. PHYSICAL HAZARDS Not classified. HEALTH HAZARDS Not classified. ENVIRONMENTAL HAZARDS LABEL ELEMENTS, INCLUDING PRECAUTIONARY STATEMENTS None. HAZARD SYMBOL(S) SIGNAL WORD None. HAZARD STATEMENT(S) The mixture does not meet the criteria for classification. PRECAUTIONARY STATEMENT(S) PREVENTION Observe good industrial hygiene practices. RESPONSE Wash hands after handling. STORAGE Store away from incompatible materials. DISPOSAL Dispose of waste and residues in accordance with local authority requirements. OTHER HAZARDS WHICH DO NOT RESULT IN CLASSIFICATION In the event of accidental injection, an allergic reaction may occur. SUPPLEMENTAL INFORMATION None. 3. COMPOSITION/INFORMATION ON INGREDIENTS MIXTURE CONCENTRATION OF INGREDIENTS IDENTITY OF CHEMICAL INGREDIENTS 0.01 CAS NUMBER AND OTHER UNIQUE IDENTIFIERS 54-64-8 Thimerosal 100 µ g/mL Not established Hendra virus HeV soluble G (sG) protein * Not assigned Synthetic adjuvant 1 / 8 Material name: Equivac HeV 3298 SDS AUSTRALIA *Designates that a specific chemical identity and/or percentage of composition has been withheld as a trade secret. COMPOSITION COMMENTS 4. FIRST-AID MEASURES DESCRIPTION OF NE Read the complete document